Blog

Oct 8, 2021

Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make

Posted by in categories: biotech/medical, government, health

A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of Covid-19, costs $17.74 to produce, according to a report (pdf) issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price. (taxpayer funded mind you)


The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.

Comments are closed.